Prof. Carlos Silva Lopes, who studied 373 breast carcinomas diagnosed consecutively in Angola, verified that the molecular profile (Like) was Luminal A—23.8%, Luminal B—27.1%, Luminal B/HER2—8.2%, HER2—14.7% and triple negative—26.2%. Here, ERBB2 is linked to breast carcinoma.